Drainless Thyroidectomy by the Sutureless Technique for Benign Thyroid Diseases
Safety and Feasibility of Drainless Thyroid Surgery for Benign Thyroid Diseases Using the Sutureless Technique, Rrandomized Controlled Trial
연구 개요
상태
정황
상세 설명
Thyroidectomy for benign thyroid diseases is commonly performed with routine placement of surgical drains to prevent postoperative hematoma or seroma. However, drain use may be associated with increased pain, infection risk, prolonged hospital stay, and patient discomfort. Advances in surgical techniques, particularly the use of sutureless energy-based hemostatic devices, have raised the possibility of safely omitting routine drain placement in selected patients.
This prospective randomized controlled trial aims to assess the safety and feasibility of drainless thyroid surgery in patients with benign thyroid diseases. Eligible patients undergoing thyroidectomy are randomly allocated into two groups: a drainless group, in which no postoperative drain is inserted, and a control group, in which a conventional closed suction drain is placed.
All surgeries are performed using a standardized sutureless technique for hemostasis. Patients are followed postoperatively to evaluate surgical and clinical outcomes, including postoperative bleeding or hematoma, seroma formation, wound complications, hypocalcemia, recurrent laryngeal nerve injury, postoperative pain, length of hospital stay, and need for reintervention or readmission.
The results of this study are expected to clarify whether drainless thyroid surgery using a sutureless technique is a safe and feasible alternative to conventional drain placement in benign thyroid surgery and may help optimize postoperative care and patient comfort
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Minya, 이집트, 61111
- Minia University
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Adult patients (≥18 years)
- Benign thyroid disease confirmed by: clinical assessment, ultrasonography, and fine-needle aspiration cytology (Bethesda II)
- Indicated for elective hemithyroidectomy or total thyroidectomy
- Euthyroid or adequately controlled thyroid function
Exclusion Criteria:
- Thyroid malignancy or indeterminate cytology
- Re-operative thyroid surgery
- Retrosternal goiter
- Coagulation disorders
- Patients on anticoagulation that could not be safely discontinued
- Concomitant neck surgery
- Severe uncontrolled systemic illness (ASA IV or higher)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: thyroidectomy without drain
Participants in this arm undergo sutureless thyroidectomy procedure, but no surgical drain is placed afterward.
The aim is to evaluate whether omitting the drain affects outcomes such as postoperative surgical site complications (like pain, infection, seroma, hematoma) compared with the drained approach.
|
Participants undergo sutureless thyroidectomy procedure but no drain is placed postoperatively.
The goal is to assess whether omitting the drain affects postoperative outcomes such as pain, seroma, hematoma, infection, or overall recovery, while maintaining safety.
|
|
활성 비교기: thyroidectomy with drain
Participants in this arm undergo sutureless thyroidectomy for benign thyroid disease with placement of a subcutaneous suction drain at the end of the procedure.
The purpose of using the drain is to evacuate any postoperative fluid such as blood or serous fluid from the surgical site to theoretically reduce complications such as hematoma or seroma accumulation.
|
Participants undergo sutureless thyroidectomy for benign thyroid disease with placement of a subcutaneous suction drain.
The drain is intended to evacuate postoperative fluid (blood or serous fluid) to reduce the risk of complications such as hematoma or seroma formation.
The surgical technique itself follows conventional sutureless thyroidectomy principles.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence of postoperative neck hematoma requiring intervention
기간: Within 48 hours postoperatively
|
Any postoperative cervical hematoma causing airway compromise or requiring surgical re-exploration or invasive evacuation
|
Within 48 hours postoperatively
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
1. Overall postoperative complication rate
기간: Within 30 days postoperatively
|
Definition: Composite of hematoma, seroma, wound infection, hypocalcemia, and recurrent laryngeal nerve injury
|
Within 30 days postoperatively
|
|
2. Seroma formation
기간: Within 14 days postoperatively
|
Clinically or ultrasonographically detected fluid collection requiring aspiration
|
Within 14 days postoperatively
|
|
3. Postoperative hypocalcemia
기간: Within 72 hours postoperatively
|
Corrected serum calcium < 8.5 mg/dL and/or symptoms requiring calcium supplementation
|
Within 72 hours postoperatively
|
|
Recurrent laryngeal nerve injury
기간: Within 30 days postoperatively
|
Postoperative vocal cord paresis/paralysis confirmed by laryngoscopy
|
Within 30 days postoperatively
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
양성 갑상선 결절에 대한 임상 시험
-
Silkiss Eye SurgeryJazz Pharmaceuticals; Smith-Kettlewell Eye Research Institute; Benign Essential Blepharospasm...완전한
-
University of PennsylvaniaRevance Therapeutics, Inc.아직 모집하지 않음안검경련 | Blepharospasm, Benign Essential | 왼쪽 눈꺼풀의 안검 경련 | 오른쪽 눈꺼풀의 안검 경련 | 양쪽 눈꺼풀의 안검 경련미국